Response to the letter to the editor by Hafer and Johnson concerning 'Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain'.

Authors

Thomas Ottoboni, Heron Therapeutics, Inc
Barry Quart, Heron Therapeutics, Inc
Jayne Pawasauskas, University of Rhode Island
Joseph F. Dasta, Ohio State University; University of Texas, Austin
Richard A. Pollak, San Antonio, TX
Eugene R. Viscusi, Thomas Jefferson UniversityFollow

Document Type

Response or Comment

Publication Date

12-1-2020

Comments

This article is the author’s final published version in Regional Anesthesia and Pain Medicine, Volume 45, Issue 12, December 2020, Pages 1031-1032.

The published version is available at https://doi.org/10.1136/rapm-2020-101488. Copyright © Ottoboni et al.

Recommended Citation

Ottoboni, Thomas; Quart, Barry; Pawasauskas, Jayne; Dasta, Joseph F.; Pollak, Richard A.; and Viscusi, Eugene R., "Response to the letter to the editor by Hafer and Johnson concerning 'Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain'." (2020). Department of Anesthesiology Faculty Papers. Paper 66.
https://jdc.jefferson.edu/anfp/66

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

PubMed ID

32487703

Language

English